Forkhead Box Protein M1 (FOXM1): Prospective Prognostic Biomarker and Therapeutic Targets in Oral Cancer-Reference-Cited by-同舟云学术

Forkhead Box Protein M1 (FOXM1): Prospective Prognostic Biomarker and Therapeutic Targets in Oral Cancer

Published:2023-12 Issue:11 Volume:23 Page:834-836
ISSN:1568-0096
Container-title:Current Cancer Drug Targets
language:en
Short-container-title:CCDT

Author:

Venkidasamy Baskar¹,Samynathan Ramkumar²³,Govidasamy Rajakumar⁴

Affiliation:

1. Department of Oral & Maxillofacial Surgery, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, 600 077, Tamil Nadu, India

2. R&D Division, Alchem Diagnostics, No. 1/1, Gokhale Street, Ram Nagar, Coimbatore, 641009, Tamil Nadu, India

3. Deaprtment of Biotechnology, Bharathiar University, Coimbatore, Tamil Nadu, India

4. Department of Orthodontics, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, 600 077, Tamil Nadu, India

Abstract

Publisher

Bentham Science Publishers Ltd.

Subject

Cancer Research,Drug Discovery,Pharmacology,Oncology

Reference13 articles.

1. Down C.F.; Millour J.; Lam E.W.F.; Watson R.J.; Binding of FoxM1 to G2/M gene promoters is dependent upon B-Myb. Biochim Biophys Acta Gene Regul Mech 2012,1819(8),855-862

2. Gu C.; Jing X.; Holman C.; Sompallae R.; Zhan F.; Tricot G.; Yang Y.; Janz S.; Upregulation of FOXM1 leads to diminished drug sensitivity in myeloma. BMC Cancer 2018,18(1),1152

3. Park Y.Y.; Jung S.Y.; Jennings N.B.; Rodriguez-Aguayo C.; Peng G.; Lee S.R.; Kim S.B.; Kim K.; Leem S.H.; Lin S.Y.; Lopez-Berestein G.; Sood A.K.; Lee J.S.; FOXM1 mediates Dox resistance in breast cancer by enhancing DNA repair. Carcinogenesis 2012,33(10),1843-1853

4. Harada K.; Ferdous T.; Minami H.; Mishima K.; Prognostic significance of FOXM1 in oral squamous cell carcinoma patients treated by docetaxel-containing regimens. Mol Clin Oncol 2018,10(1),29-36

5. Ferdous T.; Harada K.; Ueyama Y.; High expression of FOXM1 is a potential prognostic marker for oral squamous cell carcinoma patients treated with docetaxel-containing regimens. Ann Oncol 2016,27,vi348